The role of RAD51 in the biology and therapeutic response of high-grade metastatic breast cancers. (#5)

9:45 AM

Adrian P Wiegmans

Symposium 1 - Clinical and Translational Aspects

Rational combination therapy against triple-negative breast cancer (#62)

5:20 PM

Fares Al-Ejeh

Poster Session - Clinical Aspects

Molecular pathways and therapeutic targets for triple-negative breast cancer (#140)

5:20 PM

Mariska Miranda

Poster Session - Stress, Chaperones, Metabolism

CEP55; a new target for prevention of breast cancer progression and metastasis (#220)

4:40 PM

Jacinta Simmons

Poster Session - Organotropism

Characterisation of a novel breast cancer cell line, BCBM1, derived from a bone metastatic lesion of a breast cancer patient (#215)

4:40 PM

Julie K Johnson

Poster Session - Organotropism

Uncovering molecular mechanisms involved in metastasis to the brain (#83)

5:20 PM

Jodi M Saunus

Poster Session - Clinical Aspects

Sub1 is a marker of aggressive breast cancer (#84)

5:20 PM

Wei Shi

Poster Session - Clinical Aspects